Temporal evolution of primary angiitis of the central nervous system (PACNS) on MRI following immunosuppressant treatment.
Brain
Contrast media
Magnetic resonance imaging
Vasculitis
Journal
Insights into imaging
ISSN: 1869-4101
Titre abrégé: Insights Imaging
Pays: Germany
ID NLM: 101532453
Informations de publication
Date de publication:
09 Jun 2024
09 Jun 2024
Historique:
received:
29
01
2024
accepted:
26
04
2024
medline:
10
6
2024
pubmed:
10
6
2024
entrez:
9
6
2024
Statut:
epublish
Résumé
To systematically analyse the time course of vessel wall enhancement and associated stenosis in patients with primary angiitis of the central nervous system (PACNS) following immunosuppressive therapy. Two neuroradiologists retrospectively analysed MRIs of patients with PACNS seen at the Bern University Hospital and the St. Gallen Cantonal Hospital between 2015 and 2020. MRIs were examined for the presence of vessel wall enhancement, length of vessel wall enhancement (mm), circumferential extent of enhancement (degree) and degree of stenosis (%). Descriptive statistics and measurements of interobserver reliability were obtained. To investigate the temporal profiles of the variables following the commencement of immunosuppressant treatment, four series of Bayesian generalised multi-level models were generated. A total of 23 patients with 43 affected vessels identified from 209 MRI exams were evaluated (mean follow-up: 715 days, standard deviation ± 487 days), leading to a complete dataset of 402 entries. Vessel wall enhancement and circumferential extent of enhancement decreased for approximately 1 year after the initiation of immunosuppressant therapy. Changes were more pronounced in younger patients. Disappearance of vessel wall enhancement (in at least one vessel) was seen in about half of patients after a median of 172 days interquartile range 113-244, minimum 54 days, maximum 627 days. This study evaluated the typical time course of vessel wall enhancement in patients with PACNS. Our results could be a useful reference for radiologists and clinicians interpreting follow-up imaging in patients with PACNS. Routine clinical exams can be interpreted with more confidence when radiologists are aware of the typical temporal evolution of vessel wall enhancement in patients with primary angiitis of the central nervous system after initiation of immunosuppressive therapy. Few data exist for vessel wall imaging of primary angiitis of the central nervous system. Following immunosuppressant therapy, vessel wall enhancement decreases for approximately one year. These results may serve as a reference for radiologists performing follow-up imaging.
Identifiants
pubmed: 38853223
doi: 10.1186/s13244-024-01710-y
pii: 10.1186/s13244-024-01710-y
doi:
Types de publication
Journal Article
Langues
eng
Pagination
140Informations de copyright
© 2024. The Author(s).
Références
Beuker C, Strunk D, Rawal R et al (2021) Primary Angiitis of the CNS: A Systematic Review and Meta-analysis. Neurol Neuroimmunol Neuroinflamm. 8:e1093. https://doi.org/10.1212/NXI.0000000000001093
Kraemer M, Berlit P (2021) Primary central nervous system vasculitis - an update on diagnosis, differential diagnosis and treatment. J Neurol Sci 424:117422. https://doi.org/10.1016/j.jns.2021.117422
doi: 10.1016/j.jns.2021.117422
pubmed: 33832773
Salvarani C, Brown RD, Hunder GG (2012) Adult primary central nervous system vasculitis. Lancet 380:767–777. https://doi.org/10.1016/S0140-6736(12)60069-5
doi: 10.1016/S0140-6736(12)60069-5
pubmed: 22575778
Giannini C, Salvarani C, Hunder G, Brown RD (2012) Primary central nervous system vasculitis: pathology and mechanisms. Acta Neuropathol 123:759–772. https://doi.org/10.1007/s00401-012-0973-9
doi: 10.1007/s00401-012-0973-9
pubmed: 22421812
Mossa-Basha M, Shibata DK, Hallam DK et al (2017) Added value of vessel wall magnetic resonance imaging for differentiation of nonocclusive intracranial vasculopathies. Stroke 48:3026–3033. https://doi.org/10.1161/STROKEAHA.117.018227
doi: 10.1161/STROKEAHA.117.018227
pubmed: 29030476
pmcid: 5687293
Becker J, Horn PA, Keyvani K et al (2017) Primary central nervous system vasculitis and its mimicking diseases - clinical features, outcome, comorbidities and diagnostic results - a case control study. Clin Neurol Neurosurg 156:48–54. https://doi.org/10.1016/j.clineuro.2017.03.006
doi: 10.1016/j.clineuro.2017.03.006
pubmed: 28324788
Schuster S, Bachmann H, Thom V et al (2017) Subtypes of primary angiitis of the CNS identified by MRI patterns reflect the size of affected vessels. J Neurol Neurosurg Psychiatry 88:749–755. https://doi.org/10.1136/jnnp-2017-315691
doi: 10.1136/jnnp-2017-315691
pubmed: 28705900
Bersano A, Kraemer M, Burlina A et al (2021) Heritable and non-heritable uncommon causes of stroke. J Neurol 268:2780–2807. https://doi.org/10.1007/s00415-020-09836-x
doi: 10.1007/s00415-020-09836-x
pubmed: 32318851
Salvarani C, Brown RD, Hunder GG (2012) Adult primary central nervous system vasculitis: an update. Curr Opin Rheumatol 24:46–52. https://doi.org/10.1097/BOR.0b013e32834d6d76
doi: 10.1097/BOR.0b013e32834d6d76
pubmed: 22157412
Kraemer M, Berlit P (2011) Primary central nervous system vasculitis: clinical experiences with 21 new European cases. Rheumatol Int 31:463–472. https://doi.org/10.1007/s00296-009-1312-x
doi: 10.1007/s00296-009-1312-x
pubmed: 20024553
Birnbaum J, Hellmann DB (2009) Primary angiitis of the central nervous system. Arch Neurol 66:704–709. https://doi.org/10.1001/archneurol.2009.76
doi: 10.1001/archneurol.2009.76
pubmed: 19506130
Lindenholz A, van der Kolk AG, Zwanenburg JJM, Hendrikse J (2018) The use and pitfalls of intracranial vessel wall imaging: how we do it. Radiology 286:12–28. https://doi.org/10.1148/radiol.2017162096
doi: 10.1148/radiol.2017162096
pubmed: 29261469
Mossa-Basha M, Zhu C, Yuan C et al (2022) Survey of the American Society of Neuroradiology Membership on the use and value of intracranial vessel wall MRI. AJNR Am J Neuroradiol 43:951–957. https://doi.org/10.3174/ajnr.A7541
doi: 10.3174/ajnr.A7541
pubmed: 35710122
pmcid: 9262066
Thaler C, Kaufmann-Bühler A-K, Gansukh T et al (2019) Neuroradiologic characteristics of primary angiitis of the central nervous system according to the affected vessel size. Clin Neuroradiol 29:37–44. https://doi.org/10.1007/s00062-017-0622-8
doi: 10.1007/s00062-017-0622-8
pubmed: 28875326
Cheng-Ching E, Jones S, Hui FK et al (2015) High-resolution MRI vessel wall imaging in varicella zoster virus vasculopathy. J Neurol Sci 351:168–173. https://doi.org/10.1016/j.jns.2015.02.017
doi: 10.1016/j.jns.2015.02.017
pubmed: 25732801
pmcid: 4385445
Obusez EC, Hui F, Hajj-Ali RA et al (2014) High-resolution MRI vessel wall imaging: spatial and temporal patterns of reversible cerebral vasoconstriction syndrome and central nervous system vasculitis. AJNR Am J Neuroradiol 35:1527–1532. https://doi.org/10.3174/ajnr.A3909
doi: 10.3174/ajnr.A3909
pubmed: 24722305
pmcid: 7964439
Patzig M, Forbrig R, Küpper C et al (2022) Diagnosis and follow-up evaluation of central nervous system vasculitis: an evaluation of vessel-wall MRI findings. J Neurol 269:982–996. https://doi.org/10.1007/s00415-021-10683-7
doi: 10.1007/s00415-021-10683-7
pubmed: 34236502
North American Symptomatic Carotid Endarterectomy Trial Collaborators, Barnett HJM, Taylor DW et al (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325:445–453. https://doi.org/10.1056/NEJM199108153250701
doi: 10.1056/NEJM199108153250701
Finn AV, Nakano M, Narula J et al (2010) Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 30:1282–1292. https://doi.org/10.1161/ATVBAHA.108.179739
doi: 10.1161/ATVBAHA.108.179739
pubmed: 20554950
Edjlali M, Qiao Y, Boulouis G et al (2020) Vessel wall MR imaging for the detection of intracranial inflammatory vasculopathies. Cardiovasc Diagn Ther 10:1108–1119. https://doi.org/10.21037/cdt-20-324
doi: 10.21037/cdt-20-324
pubmed: 32968663
pmcid: 7487407
Ryoo S, Cha J, Kim SJ et al (2014) High-resolution magnetic resonance wall imaging findings of Moyamoya disease. Stroke 45:2457–2460. https://doi.org/10.1161/STROKEAHA.114.004761
doi: 10.1161/STROKEAHA.114.004761
pubmed: 24947295